| Name | Title | Contact Details |
|---|
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Pacific Sleep Disorders Center is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.
Opioids could kill nearly 500,000 Americans in the next decade. But we can solve this epidemic together.
St. Tammany Parish Hospital delivers today`s life-improving procedures with the latest technology, highest quality and the utmost care to area residents. From wellness and prevention to diagnosis, treatment, rehabilitation and recovery, the St. Tammany Parish Hospital system delivers the very latest technology, the most accomplished specialists and highly personalized, caring staff to ensure patients and their families receive world-class healthcare close to home. St. Tammany has higher quality ratings from The Joint Commission (qualitycheck.org) than other hospitals in our region. STPH consistently earns national and local recognition for quality, innovation and patient satisfaction from Press Ganey, Reuters Thomson, VHA Leadership Awards, Employer of Choice, Best Places to Work and Best of the Northshore rankings. Please tell any member of the staff, a supervisor or the Guest Services Department (898-4669) if there is anything we can do to make a patient`s stay more comfortable. We want the opportunity to address it. St. Tammany Parish Hospital is accredited by The Joint Commission, whose standards deal with quality and safety of care and environment. Patients have the right to contact the Joint Commission`s Office of Quality Monitoring for concerns about your care either by calling (800) 994-6610 or by visiting jointcommission.org/. You may also speak with the Louisiana Department of Health and Hospitals by calling (225) 342-6429 or the U.S. Department of Health and Human Services at (877) 696-6775. St. Tammany Parish Hospital campuses are completely tobacco-free. As the largest healthcare provider in the parish, we eliminated tobacco as part of our mission to serve the community`s healthcare needs. We recognize adults` right to use tobacco but we know its ill effects and institute this policy for the safety and health of our patients, families, employees, volunteers and physicians. Thank you for not smoking. STPH is a self-supporting not-for-profit community hospital; it receives no tax funding.